Dergiler / Journal of Clinical Research in Pediatric Endocrinology / 2016 / Cilt: 8 - Sayı: 2

Idiopathic Hypogonadotropic Hypogonadism Caused by Inactivating Mutations in SRA1

Sayfa
125–134
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Furthermore, SRA1 with its alternative products and functionality may provide a potential explanation for the versatility and complexity of the pubertal process.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: What initiates the pubertal process in humans and other mammals is still unknown.
📊
Temel Bulgular & Veri:Results: Our studies revealed three independent families in which IHH/delayed puberty is associated with inactivating SRA1 variants.
💡
Sonuç & Katkı:Furthermore, SRA1 with its alternative products and functionality may provide a potential explanation for the versatility and complexity of the pubertal process.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: What initiates the pubertal process in humans and other mammals is still unknown. We hypothesized that gene(s) taking roles in triggering human puberty may be identified by studying a cohort of idiopathic hypogonadotropic hypogonadism (IHH). Methods: A cohort of IHH cases was studied based on autozygosity mapping coupled with whole exome sequencing. Results: Our studies revealed three independent families in which IHH/delayed puberty is associated with inactivating SRA1 variants. SRA1 was the first gene to be identified to function through its protein as well as noncoding functional ribonucleic acid products. These products act as co-regulators of nuclear receptors including sex steroid receptors as well as SF-1 and LRH-1, the master regulators of steroidogenesis. Functional studies with a mutant SRA1 construct showed a reduced co-activation of ligand-dependent activity of the estrogen receptor alpha, as assessed by luciferase reporter assay in HeLa cells. Conclusion: Our findings strongly suggest that SRA1 gene function is required for initiation of puberty in humans. Furthermore, SRA1 with its alternative products and functionality may provide a potential explanation for the versatility and complexity of the pubertal process.

🔖

Bu Makaleye Atıf Yap

GEDİK, L. D. K., COOPER, C., DARCAN, Ş., CARR, I. M., ÖZEN, S., YAN, Y., HAMEDANİ, M. K., GÜRBÜZ, F., MENGEN, E., TURAN, İ., ULUBAY, A., AKKUŞ, G., YÜKSEL, B., TOPALOĞLU, A. K., LEYGUE, E. (2016). Idiopathic Hypogonadotropic Hypogonadism Caused by Inactivating Mutations in SRA1. Journal of Clinical Research in Pediatric Endocrinology, Cilt: 8 - Sayı: 2, 125–134. https://ajindex.com/articles/270501

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Semple RK, Topaloglu AK. The recent genetics of hypogonadotrophic hypogonadism - novel insights and new questions. Clin Endocrinol (Oxf) 2010;72:427-435. Epub 2009 Aug 29 2. Topaloglu AK, Reimann F, Guclu M, Yalin AS, Kotan LD, Porter KM, Serin A, Mungan NO, Cook JR, Ozbek MN, Imamoglu S, Akalin NS, Yuksel B, O'Rahilly S, Semple RK. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat Genet 2009;41:354-358. Epub 2008 Dec 11 3. Topaloglu AK, Tello JA, Kotan LD, Ozbek MN, Yilmaz MB, Erdogan S, Gurbuz F, Temiz F, Millar RP, Yuksel B. Inactivating KISS1 mutation and hypogonadotropic hypogonadism. N Engl J Med 2012;366:629-635. 4. Lehman MN, Coolen LM, Goodman RL. Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropinreleasing hormone secretion. Endocrinology 2010;151:3479- 3489. Epub 2010 May 25 5. Topaloglu AK, Kotan LD. Genetics of hypogonadotropic hypogonadism. Endocr Dev 2016;29:36-49. Epub 2015 Dec 17 6. Chooniedass-Kothari S, Vincett D, Yan Y, Cooper C, Hamedani M, Myal Y, Leygue E. The protein encoded by the functional steroid receptor RNA activator is a new modulator of ER alpha transcriptional activity. Febs Lett 2010;584:1174-1180. Epub 2010 Feb 11 7. Yan Y, Skliris GP, Penner C, Chooniedass-Kothari S, Cooper C, Nugent Z, Blanchard A, Watson PH, Myal Y, Murphy LC, Leygue E. Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptorpositive/node-negative/younger breast cancer patients. Breast Cancer Res 2009;11:67. 8. Lanz RB, McKenna NJ, Onate SA, Albrecht U, Wong J, Tsai SY, Tsai MJ, O'Malley BW. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 1999;97:17-27. 9. Deblois G, Giguere V. Ligand-independent coactivation of ERalpha AF-1 by steroid receptor RNA activator (SRA) via MAPK activation. J Steroid Biochem Mol Bio 2003;85:123- 131. 10. Klinge CM, Jernigan SC, Mattingly KA, Risinger KE, Zhang J. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. J Mol Endocrinol 2004;33:387-410. 11. Xu B, Yang WH, Gerin I, Hu CD, Hammer GD, Koenig RJ. Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis. Mol Cell Biol 2009;29:1719-1